Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gillette Antiperspirant Brands Allocated $25 Mil. In 1999 Marketing Support

This article was originally published in The Tan Sheet

Executive Summary

Gillette will support its Gillette Series, Right Guard and Soft & Dri antiperspirant and deodorant brands with a $25 mil. marketing budget in 1999. As part of the effort, a "contemporary" print and TV effort will break in April for Right Guard, with ads for Soft & Dri expected to follow in the summer.

You may also be interested in...



Right Guard Xtreme Sport $61 Mil. Marketing Campaign Targets Young Men

Gillette is spending $61 mil. to market its new Right Guard Xtreme Sport antiperspirant/deodorant lineup to a younger set of active consumers ages 10 to 25, the company said.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089357

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel